TAF1 and prostate cancer: Overexpression or dysregulation of TAF1, driven by genetic and epigenetic changes, was found in NSCLC, where it activates TGFβ1 [118] and is associated with progression of human prostate cancers to the lethal castration-resistant state, is common in various cancers [119].